GlycaNova: Launch of Ganodex(TM)
Innovative skin cream treatment for problems such as eczema and psoriasis now available online
(firmenpresse) - LONDON, UNITED KINGDOM -- (Marketwired) -- 06/04/13 -- GlycaNova, the Norwegian biotechnology company focused on over-the-counter and prescription products for immune system disorders, is pleased to announce the launch of Ganodex™, its highly innovative, over-the-counter skin cream treatment for problems such as eczema and psoriasis.
Ganodex™ has been developed by GlycaNova researchers over the past 4 years, using a proprietary extract from medicinal mushrooms as the active ingredient.
Initial trial results show that Ganodex™ has the ability to dramatically improve symptoms of psoriasis and eczema. Formulated as a skin cream, daily application to the affected skin stimulates and regulates skin cells, thereby improving the skin condition.
Ganodex™ contains 100% natural ingredients. Common side effects, such as drying out of the skin often experienced with creams containing cortisone and parabenes, have not been seen in patients using Ganodex™.
GlycaNova is pleased to announce Ganodex™ is now available for purchase through its dedicated website, .
Bjorn Kristiansen, CEO of GlycaNova, commented: "We are delighted to be able to offer psoriasis and eczema sufferers a completely new and natural alternative to steroid-based treatments. Those who have used Ganodex have experienced such positive results that we are pleased to be able to launch the product online to give wider access to this highly effective treatment."
Notes for editors:
About GlycaNova
GlycaNova is a Norwegian biotechnology company focused on developing products that boost the immune system. It is using its proprietary technology in triple helix beta-glucans to develop a number of natural medicines for over-the-counter and prescription use. Based in Fredrikstad, Norway, GlycaNova is a privately held company founded in 2009. For further information, please visit .
About Ganodex™
Ganodex™ is a skin cream developed by GlycaNova as an over-the-counter treatment for psoriasis. The active ingredient in Ganodex™ is a proprietary triple helix beta glucan produced by GlycaNova from the medicinal mushroom Ganoderma lucidum. The daily application of Ganodex™ to the affected skin stimulates the immune cells in the skin and modulates the skin's immune system, thereby improving problematic skin conditions.
Ganodex™ contains ingredients only from natural sources. It does not contain parabens, steroids or tar and therefore avoids common side effects such as thin, damaged or irritated skin. For further information, please visit .
About Psoriasis
This chronic immune system disorder presents itself as red and scaly skin on different parts of the body. Psoriasis can be inherited or occur in people with compromised immune systems or with other immune system disorders that cause the skin cells to divide extremely rapidly. For more information on psoriasis, please visit: .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.06.2013 - 06:11 Uhr
Sprache: Deutsch
News-ID 266002
Anzahl Zeichen: 0
contact information:
Town:
LONDON, UNITED KINGDOM
Kategorie:
Advertising, PR and Marketing
Diese Pressemitteilung wurde bisher 217 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GlycaNova: Launch of Ganodex(TM)"
steht unter der journalistisch-redaktionellen Verantwortung von
GlycaNova (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
